Hongliang Chen

Dr. Hongliang Chen

orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2018 in The Breast
Verified
Journal Article
Closed access
MWMaoli Wang
Maoli Wang
HCHongliang Chen
Hongliang Chen
KWKejin Wu
Kejin Wu
ADAng Ding
Ang Ding
MZMingdi Zhang
Mingdi Zhang
PZPeng Zhang
Peng Zhang

11 May 2016 in SpringerPlus
Verified
Journal Article
Open access
PDF file
HCHongliang Chen
Hongliang Chen
ADAng Ding
Ang Ding
MWMao-Li Wang
Mao-Li Wang
To evaluate the prognostic effect of central obesity on triple negative breast cancer (TNBC). 206 TNBC patients treated from June 2006 to June 2015 were enrolled retrospectively. Body mass index (BMI) ≥25 kg/m2 was the standard of obesity and waist circumference ≥80 cm was the standard of central obesity. Patient and tumor characteristics were compared between obesity categories. Survival differences between obesity categories were assessed with log-rank test in the univariate analysis and prognostic factors were then investigated by Cox regression analysis. 81 cases were with obesity (39.3 %). 71 cases were with central obesity (34.5 %). Patients with obesity or central obesity tended to be older (P = 0.022 for obesity; P = 0.013 for central obesity) and to have larger tumor size (P = 0.027 for obesity; P = 0.027 for central obesity). By Cox regression analysis, central obesity (DFS: HR 1.759; 95 % CI 1.009–3.065; P = 0.046. OS: HR 2.297; 95 % CI 1.184–4.456; P = 0.014) was identified as an independent prognostic factor. For central obesity with BMI ≥ 25 kg/m2, the prognostic effect was more apparent (DFS: HR 1.845; 95 % CI 1.059–3.212; P = 0.031. OS: HR 2.377; 95 % CI 1.230–4.593; P = 0.010). Central obesity, especially with high BMI, was an independent prognostic factor for TNBC.

26 October 2017 in Cancer Medicine
Verified
Journal Article
Open access
PDF file
HCHongliang Chen
Hongliang Chen
KWKejin Wu
Kejin Wu
MWMaoli Wang
Maoli Wang
FWFuwen Wang
Fuwen Wang
MZMingdi Zhang
Mingdi Zhang
PZPeng Zhang
Peng Zhang
There are controversies in the comparison of overall survival between invasive micropapillary carcinoma of the breast (IMPC) and invasive ductal carcinoma (IDC). The objective of this study was to compare the long‐term survival outcome between non‐metastatic IMPC and IDC. The Surveillance, Epidemiology, and End Results database was searched to identify women with non‐metastatic IMPC and IDC diagnosed between 2001 and 2013. Comparisons of patient and tumor characteristics were performed using Pearson's chi‐square. The propensity score matching method was applied with each IMPC matched to one IDC. Breast cancer‐specific survival (BCSS) and overall survival (OS) were estimated using the Kaplan–Meier product limit method and compared across groups using the log‐rank statistic. Multivariate analysis was performed through Cox models. IMPC was presented with aggressive clinical presentations such as larger tumor, more positive lymph nodes, and more advanced stage compared with IDC. A higher rate of estrogen receptor (ER)/progesterone receptor (PR) positivity was also observed in IMPC. With a median follow‐up of 64 months, IMPC had a better BCSS (P = 0.031) and OS (P = 0.012) compared with IDC. In a case–control analysis IMPC was still an independent favorable prognostic factor for BCSS (HR = 0.410, P < 0.001, 95% CI: 0.293–0.572) and OS (HR = 0.497, P < 0.001, 95% CI: 0.387–0.637). In subgroup analysis, IMPC always showed a better survival outcome compared with IDC except in AJCC stage I and histologic grade I disease. IMPC has a better long‐term survival outcome compared with IDC in spite of its highly aggressive clinical presentation.

19 November 2018 in Annals of Surgical Oncology
Verified
Journal Article
Closed access
PDF file
MWMaoli Wang
Maoli Wang
KWKejin Wu
Kejin Wu
PZPeng Zhang
Peng Zhang
MZMingdi Zhang
Mingdi Zhang
ADAng Ding
Ang Ding
HCHongliang Chen
Hongliang Chen


7 July 2020 in Annals of Surgical Oncology
Verified
Journal Article
Closed access
PDF file
MZMingdi Zhang
Mingdi Zhang
KWKejin Wu
Kejin Wu
PZPeng Zhang
Peng Zhang
MWMaoli Wang
Maoli Wang
FBFang Bai
Fang Bai
HCHongliang Chen
Hongliang Chen